Highbridge Capital Management’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$40.6K | – | 287 |
|
|
2025
Q1 | – | Hold |
0
| – | -$32.4K | – | 196 |
|
|
2024
Q4 | – | Hold |
0
| – | -$26.8K | – | 262 |
|
|
2024
Q3 | – | Hold |
0
| – | -$14.9K | – | 262 |
|
|
2024
Q2 | – | Hold |
0
| – | -$27.5K | – | 285 |
|
|
2024
Q1 | – | Hold |
0
| – | -$12.4K | – | 255 |
|
|
2023
Q4 | – | Hold |
0
| – | -$52.1K | – | 275 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 249 |
|